Does Methadone Show Up on a Drug Test? Panels Explained

Quick answer: Yes, but only if the test includes methadone. Standard 5-panel and DOT 5-panel urine tests do not detect it. A dedicated methadone (MTD) test, commonly with a 300 ng/mL cutoff, detects methadone or its EDDP metabolite in urine for several days after use.

• Methadone is not an "opiate" on a standard panel; it is a synthetic opioid and needs its own test line.
• Common instant-test cutoff is 300 ng/mL for methadone; confirm the cutoff printed on each device.
• Positive screens are presumptive; send them to a lab for confirmation (GC-MS or LC-MS/MS) before acting.

Does methadone show up on a standard drug test?

Methadone does not show up on a standard 5-panel or 10-panel unless methadone is listed as one of the analytes. The opiate line on a typical panel is calibrated to morphine and codeine (commonly a 2,000 ng/mL cutoff, or 300 ng/mL on some devices). Methadone is chemically different, so it generally does not trigger that line. Always read the panel label rather than assuming "opiates" covers it.

What about DOT and federally regulated testing?

The DOT urine panel under 49 CFR Part 40 covers marijuana, cocaine, amphetamines, phencyclidine and opioids (codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, oxymorphone). Methadone is not on that list, so a DOT collection will not test for it. See the DOT Office of Drug and Alcohol Policy and Compliance for current rules. Employers can add methadone only under non-DOT, company-authority testing and must keep it separate from DOT specimens.

Which tests detect methadone?

Cutoff levels and detection windows

Instant immunoassay tests report presumptive results against a fixed cutoff. For methadone, 300 ng/mL is the common urine cutoff, and the device flags a sample negative below it. Detection typically runs several days after the last dose in urine, but it varies with dose, duration of use, metabolism, urine pH and hydration. Long-term patients can test positive longer. Oral fluid generally has a shorter window than urine. Treat any window as an estimate, not a guarantee.

Methadone versus EDDP

EDDP is the main metabolite of methadone. Some lab methods look for both. In treatment settings, finding methadone with EDDP supports ingestion by the patient, while a sample with no EDDP may prompt questions about adulteration or specimen substitution. A lab can report the distinction; an instant cup cannot.

Reading results and choosing devices

How to read an instant test

1. Check the expiration date and confirm the cutoff printed on the device.
2. Collect the specimen and check temperature within the time the instructions specify.
3. Read at the stated time only; a line, even faint, in the test region generally means negative for that drug.
4. No line in the test region is a presumptive positive.
5. No control line means the test is invalid; repeat with a new device.

For on-site programs, multi-panel urine drug test cups keep collection and screening in one step, while drug test dip cards suit high-volume settings that already have collection containers. Confirm which panels include methadone before ordering, since configurations differ.

FDA and CLIA status

Instant drug tests are regulated as in vitro diagnostic devices by the FDA. Over-the-counter and prescription-use devices have different clearance pathways, and CLIA categorization determines where a test may be used professionally. Ask your supplier for the 510(k) or CLIA-waiver documentation for the exact product and panel you plan to use, and file it with your program records.

Checklist: setting up methadone testing

• Define the purpose: treatment monitoring, probation, or employment (non-DOT).
• Choose a panel that explicitly lists methadone (MTD) and, if needed, other opioids such as buprenorphine or fentanyl.
• Verify cutoffs in ng/mL on each device.
• Collect FDA and CLIA documentation for each product.
• Write a policy for medications: patients enrolled in a methadone program are lawfully prescribed it, so a positive may be expected.
• Use validity checks (temperature, and adulterant strips where appropriate).
• Send presumptive positives and disputed results to a laboratory for confirmation.
• Train staff on reading results and documenting chain of custody.
• Keep records and handle results confidentially, following applicable privacy rules for treatment programs.

Legal and policy considerations for employers

A prescribed medication changes how a positive should be handled. Employers often route non-negative results through a medical review process so that a legitimate prescription is not treated as misuse. Requirements differ by state and by program, so have counsel review your policy. If your hiring process also includes screening beyond drug tests, Reveal Background, our sister division, handles employment background checks. For help matching panels to your program, contact American Screening Corp.

Frequently asked questions

Does methadone show up on a 5-panel drug test?

No. A standard 5-panel and the DOT 5-panel do not include methadone. You need a panel with a methadone (MTD) line or a lab test that specifically includes it.

How long does methadone stay detectable in urine?

Typically for several days after the last dose, with a longer window possible in long-term users. Dose, metabolism, urine pH and hydration all affect it, so use the window as an estimate.

Can a methadone positive be a false positive?

Immunoassay tests can occasionally cross-react with certain medications, so a presumptive positive should be confirmed by GC-MS or LC-MS/MS before any action is taken.

Does the DOT test for methadone?

No. Methadone is not on the DOT 49 CFR Part 40 urine panel. Any methadone testing an employer adds must be done under company authority, separate from DOT tests.

Sources

• SAMHSA: Methadone
• U.S. DOT Office of Drug and Alcohol Policy and Compliance
• FDA: Drugs of Abuse Tests

This article is general information, not legal or medical advice.